News
Successful informative session on U.S. Non-dilutive funding at IDIBELL
The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S. funding sources for Health Projects, that were delivered by Dr. Ana Turchetti-Maia, Director of Business Development at Freemind […]
Scientists discover the implication of a new protein involved in liver cancer
The finding has a clear clinical relevance, since it will facilitate patient selection to offer a more specific therapy
The consul general of France in Barcelona visits IDIBELL
The consul general of France in Barcelona, Cyril Piquemal, visited IDIBELL on October 23rd in order to get to know the institute and promote collaborations and synergies with French institutions. The visit took place as part of the efforts made by the French consulate to strengthen the interaction between research centers in Catalonia and France. […]
Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells
At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000. […]
Innovation for value turns Barcelona into the world capital of health innovation
The event, co-organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), will take place on November 8 at the Bellvitge University Hospital
Researchers identify a neural mechanism involved in the creation and consolidation of memories
The study of the UB and IDIBELL showed brain patterns we generate when watching a film are similar, and follow the same order, than the patterns created when the story is narrated
IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome
The project is led by Dr. Eulàlia Baselga, Area of Dermatology of the Hospital Sant Joan de Déu Barcelona, and Dr. Mariona Graupera, Bellvitge Biomedical Research Institute (IDIBELL). Its main objective is to identify a treatment aimed at reversing or improving the vascular alterations produced by the R183Q mutation in the GNAQ gene that leads to Sturge-Weber Syndrome.
Innovation for value, the first international innovation conference at IDIBELL
On November 8, IDIBELL and ITEMAS co-organize Innovation for Value (#I4V), a conference focusing on the opportunities offered by innovation and new technologies in the healthcare field. In this event, which will take place at the Bellvitge University Hospital, speakers will also analyze the new business opportunities that arise thanks to scientific innovation and the […]
A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease
Parkinson’s disease (PD) is an old age disorder that causes a series of motor deficiencies that are characteristic. Normally, the four main symptoms are hand tremor, limb stiffness, slowness and impaired balance. With the progression of the disease, patients may also experience dementia and other neurological disorders. Since the main symptoms are due to degeneration […]